Tacita Capital’s Pfizer PFE Stock Holding History

Tacita Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$69.5K	Hold	2,476	–	–	0.04%	125
2025 Q4	$61.7K	Sell	2,476 -279	-10%	-$7.04K	0.04%	132
2025 Q3	$70.2K	Hold	2,755	–	–	0.04%	123
2025 Q2	$66.8K	Buy	2,755 +1,800	+188%	+$42K	0.04%	119
2025 Q1	$24.2K	Hold	955	–	–	0.02%	168
2024 Q4	$25.3K	Hold	955	–	–	0.02%	164
2024 Q3	$27.6K	Hold	955	–	–	0.02%	156
2024 Q2	$26.7K	Hold	955	–	–	0.02%	165
2024 Q1	$26.5K	Hold	955	–	–	0.02%	167
2023 Q4	$27.5K	Hold	955	–	–	0.02%	167
2023 Q3	$31.7K	Sell	955 -750	-44%	-$26.5K	0.02%	159
2023 Q2	$63K	Hold	1,705	–	–	0.05%	125
2023 Q1	$70K	Buy	1,705 +750	+79%	+$32.4K	0.05%	111
2022 Q4	$49K	Sell	955 -120	-11%	-$5.75K	0.04%	134
2022 Q3	$47K	Hold	1,075	–	–	0.04%	124
2022 Q2	$56K	Hold	1,075	–	–	0.04%	124
2022 Q1	$56K	Hold	1,075	–	–	0.03%	136
2021 Q4	$63K	Buy	+1,075	New	+$53.3K	0.04%	123

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Tacita Capital's PFE Position: Q1 2026 in Review

Tacita Capital held its Pfizer (PFE) position steady in Q1 2026 at 2,476 shares worth $69.5K. The position accounts for 0.04% of the portfolio, ranked #125.

Tacita Capital first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $70.2K in Q3 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Tacita Capital held 2,476 shares of Pfizer worth $69.5K as of Q1 2026.
Tacita Capital left its Pfizer share count unchanged in Q1 2026.
Pfizer made up 0.04% of Tacita Capital's portfolio in Q1 2026, its #125 holding.
Tacita Capital first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
Tacita Capital's Pfizer position peaked at $70.2K in Q3 2025.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Tacita Capital's 13F filing for Q1 2026, filed 7 May 2026.